Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Commonly employed in medicinal chemistry for optimizing drug candidates due to the stability and bioavailability conferred by the tert-butyl carbamate (Boc) protecting group. Also utilized in research settings to explore structure-activity relationships in central nervous system agents and anti-inflammatory drugs.